Author

A. Winn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. A. Koshy· 1 shared A. Anderson· 1 shared A. Ganesh· 1 shared A. Hajduczki· 1 shared A. R. Henry· 1 shared A. S. Pekosz· 1 shared C. A. Hunter· 1 shared C. E. Peterson· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. A. Koshy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The latent stage of Toxoplasma gondii is targeted by the immune response and host protective

L. A. Shallberg, J. N. Eberhard, A. Winn, S. Chandrasekaran, C. J. Giuliano, E. F. Merritt, E. Willis, D. A. Christian, D. L. Aldridge, M. Bunkofske, M. Jacquet, F. Dzierszinski, E. Katifori, S. Lourido, A. A. Koshy, C. A. Hunter

This study shows immune pressure targets Toxoplasma gondii bradyzoites, which mitigate tissue damage and promote host-parasite survival.

bioRxiv · Mar 5, 2024 · PreprintMicrobiology

A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters

K. M. Wuertz, E. Barkei, W.-h. Chen, E. J. Martinez, I. E. Naouar, L. Jagodzinski, D. Paquin-Proulx, G. D. Gromowski, I. Swafford, A. Ganesh, M. Dong, X. Zeng, P. V. Thomas, R. S. Sankhala, A. Hajduczki, , Vasan

This study evaluates a SARS-CoV-2 spike ferritin nanoparticle vaccine's effectiveness against B.1.1.7 and B.1.351 variants in hamsters, showing protection against disease and viral replication.

bioRxiv · Jun 16, 2021 · PreprintImmunology